Advertisement

Changes in Opioid Prescribing for Washington Workers' Compensation Claimants After Implementation of an Opioid Dosing Guideline for Chronic Noncancer Pain: 2004 to 2010

      Abstract

      An opioid overdose epidemic emerged in the United States following increased opioid prescribing for chronic noncancer pain. In 2007, Washington State agencies implemented an opioid dosing guideline on safe prescribing for chronic noncancer pain. The objective of this population-based observational study was to evaluate opioid use and dosing before and after guideline implementation. We identified 161,283 workers aged 18 to 64 years with ≥1 opioid prescriptions in Washington Workers' Compensation, April 1, 2004, to December 31, 2010. Prevalence and incidence rates of opioid use were assessed. We compared pre- and postguideline chronic and high-dose use (≥120 mg/d) among incident users. The mean monthly prevalence of opioid use declined by 25.6% between 2004 (14.4%) and 2010 (10.7%). Fewer incident users went on to chronic opioid therapy in the postguideline period (4.7%; 95% confidence interval [CI], 4.5–5.0%) than in the preguideline period (6.3%; 95% CI, 6.1–6.6%). Compared with preguideline incident users, postguideline incident users were 35% less likely to receive high doses (adjusted odds ratio = .65; 95% CI, .59–.71). Although the extent to which decreases were due to the guidelines is uncertain, to our knowledge, this is the first report of significant decreases in chronic and high-dose prescription opioid use among incident users.

      Perspective

      Evidence-based strategies for opioid risk management are needed to help abate the epidemic of opioid-related morbidity and mortality. The study findings suggest that opioid dosing guidelines that specify a “yellow flag” dosing threshold may be a useful tool in preventing escalation of doses into ranges associated with increased mortality risk.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Agency for Healthcare Research and Quality: National Guideline Clearinghouse: Guideline summary. Available at: http://guideline.gov/content.aspx?id=23792. Accessed May 1, 2013

        • Ballantyne J.C.
        • Mao J.
        Opioid therapy for chronic pain.
        N Engl J Med. 2003; 349: 1943-1953
        • Barry D.T.
        • Irwin K.S.
        • Jones E.S.
        • Becker W.C.
        • Tetrault J.M.
        • Sullivan L.E.
        • Hansen H.
        • O'Connor P.G.
        • Schottenfeld R.S.
        • Fiellin D.A.
        Opioids, chronic pain, and addiction in primary care.
        J Pain. 2010; 11: 1442-1450
        • Bloodworth D.
        Opioids in the treatment of chronic pain: Legal framework and therapeutic indications and limitations.
        Phys Med Rehabil Clin N Am. 2006; 17: 355-379
        • Bohnert A.S.
        • Valenstein M.
        • Bair M.J.
        • Ganoczy D.
        • McCarthy J.F.
        • Ilgen M.A.
        • Blow F.C.
        Association between opioid prescribing patterns and opioid overdose-related deaths.
        J Am Med Assoc. 2011; 305: 1315-1321
        • Boudreau D.
        • Von Korff M.
        • Rutter C.M.
        • Saunders K.
        • Ray G.T.
        • Sullivan M.D.
        • Campbell C.I.
        • Merrill J.O.
        • Silverberg M.J.
        • Banta-Green C.
        • Weisner C.
        Trends in long-term opioid therapy for chronic non-cancer pain.
        Pharmacoepidemiol Drug Saf. 2009; 18: 1166-1175
        • Brixner D.I.
        • Oderda G.M.
        • Roland C.L.
        • Rublee D.A.
        Opioid expenditures and utilization in the Medicaid system.
        J Pain Palliat Care Pharmacother. 2006; 20: 5-13
        • Cantrill S.V.
        • Brown M.D.
        • Carlisle R.J.
        • Delaney K.A.
        • Hays D.P.
        • Nelson L.S.
        • O'Connor R.E.
        • Papa A.
        • Sporer K.A.
        • Todd K.H.
        • Whitson R.R.
        Clinical policy: Critical issues in the prescribing of opioids for adult patients in the emergency department.
        Ann Emerg Med. 2012; 60: 499-525
        • Caudill-Slosberg M.A.
        • Schwartz L.M.
        • Woloshin S.
        Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.
        Pain. 2004; 109: 514-519
        • Chen L.
        • Vo T.
        • Seefeld L.
        • Malarick C.
        • Houghton M.
        • Ahmed S.
        • Zhang Y.
        • Cohen A.
        • Retamozo C.
        • St Hilaire K.
        • Zhang V.
        • Mao J.
        Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients.
        J Pain. 2013; 14: 384-392
        • Chou R.
        • Fanciullo G.J.
        • Fine P.G.
        • Adler J.A.
        • Ballantyne J.C.
        • Davies P.
        • Donovan M.I.
        • Fishbain D.A.
        • Foley K.M.
        • Fudin J.
        • Gilson A.M.
        • Kelter A.
        • Mauskop A.
        • O'Connor P.G.
        • Passik S.D.
        • Pasternak G.W.
        • Portenoy R.K.
        • Rich B.A.
        • Roberts R.G.
        • Todd K.H.
        • Miaskowski C.
        Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
        J Pain. 2009; 10: 113-130
        • Cook J.D.
        Twelve year prescribing trends for fifteen different opioid, benzodiazepine, amphetamine, and barbiturate prescription drugs correlated with reports of prescription medication abuse and diversion.
        Substance Abuse and Mental Health Services Administration (SAMHSA). 2012; (Available at:) (Accessed May 1, 2013)
        • Dembe A.
        • Wickizer T.
        • Sieck C.
        • Partridge J.
        • Balchick R.
        Opioid use and dosing in the workers' compensation setting. A comparative review and new data from Ohio.
        Am J Ind Med. 2012; 55: 313-324
        • Dunn K.M.
        • Saunders K.W.
        • Rutter C.M.
        • Banta-Green C.J.
        • Merrill J.O.
        • Sullivan M.D.
        • Weisner C.M.
        • Silverberg M.J.
        • Campbell C.I.
        • Psaty B.M.
        • Von Korff M.
        Opioid prescriptions for chronic pain and overdose: A cohort study.
        Ann Intern Med. 2010; 152: 85-92
      2. FDA: Timeline of selected FDA activities & significant events addressing opioid misuse & abuse. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM332288.pdf. Accessed May 1, 2013

        • Franklin G.M.
        • Fulton-Kehoe D.
        Outcomes research in Washington state workers' compensation.
        Am J Ind Med. 1996; 29: 642-648
        • Franklin G.M.
        • Mai J.
        • Wickizer T.
        • Turner J.A.
        • Fulton-Kehoe D.
        • Grant L.
        Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002.
        Am J Ind Med. 2005; 48: 91-99
        • Franklin G.M.
        • Stover B.D.
        • Turner J.A.
        • Fulton-Kehoe D.
        • Wickizer T.M.
        Early opioid prescription and subsequent disability among workers with back injuries: The Disability Risk Identification Study Cohort.
        Spine. 2008; 33: 199-204
        • Franklin G.M.
        • Rahman E.A.
        • Turner J.A.
        • Daniell W.E.
        • Fulton-Kehoe D.
        Opioid use for chronic low back pain: A prospective, population-based study among injured workers in Washington state, 2002-2005.
        Clin J Pain. 2009; 25: 743-751
        • Franklin G.M.
        • Mai J.
        • Turner J.
        • Sullivan M.
        • Wickizer T.
        • Fulton-Kehoe D.
        Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline.
        Am J Ind Med. 2012; 55: 325-331
        • Furlan A.D.
        • Reardon R.
        • Weppler C.
        Opioids for chronic noncancer pain: A new Canadian practice guideline.
        CMAJ. 2010; 182: 923-930
        • Gomes T.
        • Mamdani M.M.
        • Dhalla I.A.
        • Paterson J.M.
        • Juurlink D.N.
        Opioid dose and drug-related mortality in patients with nonmalignant pain.
        Arch Intern Med. 2011; 171: 686-691
        • Kenan K.
        • Mack K.
        • Paulozzi L.
        Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010.
        Open Med. 2012; 6: 41-47
        • Kuehn B.M.
        FDA opioid safety plan promotes patient, physician education to prevent abuse.
        J Am Med Assoc. 2010; 304: 845
        • Laws C.
        NCCI Research Brief: Narcotics in Workers Compensation 2012 Update.
        National Council on Compensation Insurance (NCCI). 2012; (Available at:) (Accessed October 31, 2012)
        • Leverence R.R.
        • Williams R.L.
        • Potter M.
        • Fernald D.
        • Unverzagt M.
        • Pace W.
        • Parnes B.
        • Daniels E.
        • Skipper B.
        • Volk R.J.
        • Brown A.E.
        • Rhyne R.L.
        Chronic non-cancer pain: A siren for primary care—A report from the PRImary Care MultiEthnic Network (PRIME Net).
        J Am Board Fam Med. 2011; 24: 551-561
        • Manchikanti L.
        Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources.
        Pain Physician. 2006; 9: 287-321
        • Manchikanti L.
        • Abdi S.
        • Atluri S.
        • Balog C.C.
        • Benyamin R.M.
        • Boswell M.V.
        • Brown K.R.
        • Bruel B.M.
        • Bryce D.A.
        • Burks P.A.
        • Burton A.W.
        • Calodney A.K.
        • Caraway D.L.
        • Cash K.A.
        • Christo P.J.
        • Damron K.S.
        • Datta S.
        • Deer T.R.
        • Diwan S.
        • Eriator I.
        • Falco F.J.
        • Fellows B.
        • Geffert S.
        • Gharibo C.G.
        • Glaser S.E.
        • Grider J.S.
        • Hameed H.
        • Hameed M.
        • Hansen H.
        • Harned M.E.
        • Hayek S.M.
        • Helm 2nd, S.
        • Hirsch J.A.
        • Janata J.W.
        • Kaye A.D.
        • Kaye A.M.
        • Kloth D.S.
        • Koyyalagunta D.
        • Lee M.
        • Malla Y.
        • Manchikanti K.N.
        • McManus C.D.
        • Pampati V.
        • Parr A.T.
        • Pasupuleti R.
        • Patel V.B.
        • Sehgal N.
        • Silverman S.M.
        • Singh V.
        • Smith H.S.
        • Snook L.T.
        • Solanki D.R.
        • Tracy D.H.
        • Vallejo R.
        • Wargo B.W.
        American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2–guidance.
        Pain Physician. 2012; 15: S67-S116
        • Morse J.S.
        • Stockbridge H.
        • Egan K.B.
        • Mai J.
        • Wickizer T.
        • Franklin G.M.
        Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline.
        J Opioid Manag. 2011; 7: 427-433
        • Naliboff B.D.
        • Wu S.M.
        • Schieffer B.
        • Bolus R.
        • Pham Q.
        • Baria A.
        • Aragaki D.
        • Van Vort W.
        • Davis F.
        • Shekelle P.
        A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.
        J Pain. 2011; 12: 288-296
        • Nelson L.S.
        • Perrone J.
        Curbing the opioid epidemic in the United States: The risk evaluation and mitigation strategy (REMS).
        J Am Med Assoc. 2012; 308: 457-458
        • Neven D.E.
        • Sabel J.C.
        • Howell D.N.
        • Carlisle R.J.
        The development of the Washington State emergency department opioid prescribing guidelines.
        J Med Toxicol. 2012; 8: 353-359
        • Paulozzi L.J.
        • Jones C.M.
        • Mack K.
        • Rudd R.A.
        Vital signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1487-1492
        • Paulozzi L.J.
        • Baldwin G.
        • Franklin G.
        • Kerlikowske R.G.
        • Jones C.M.
        • Ghiya N.
        • Popovic T.
        CDC grand rounds: Prescription drug overdoses—A U.S. epidemic.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 10-13
        • Richarz U.
        • Jacobs A.
        • Spina E.
        How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long-term opioid therapy for chronic pain?.
        Pharmacoepidemiol Drug Saf. 2011; 21: 453-462
        • Sabel J.
        Unintentional Prescription Opioid Overdose Deaths Washington 1995-2010.
        Washington State Department of Health. 2011; (Available at:) (Accessed October 31, 2011)
        • Slevin K.A.
        • Ashburn M.A.
        Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.
        J Opioid Manag. 2011; 7: 109-115
        • StataCorp
        Stata Statistical Software: Release 12.
        StataCorp LP, College Station, TX2011
        • Stover B.D.
        • Turner J.A.
        • Franklin G.
        • Gluck J.V.
        • Fulton-Kehoe D.
        • Sheppard L.
        • Wickizer T.M.
        • Kaufman J.
        • Egan K.
        Factors associated with early opioid prescription among workers with low back injuries.
        J Pain. 2006; 7: 718-725
        • Sullivan M.D.
        • Edlund M.J.
        • Fan M.Y.
        • Devries A.
        • Brennan Braden J.
        • Martin B.C.
        Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study.
        Pain. 2008; 138: 440-449
        • Sullivan M.D.
        Limiting the potential harms of high-dose opioid therapy: Comment on “Opioid dose and drug-related mortality in patients with nonmalignant pain.”.
        Arch Intern Med. 2011; 171: 691-693
        • Tao X.G.
        • Lavin R.A.
        • Yuspeh L.
        • Bernacki E.J.
        Natural history of opioid dosage escalation post-injury: A cohort study of injured workers in the state of Louisiana.
        J Occup Environ Med. 2012; 54: 439-444
        • Trafton J.A.
        • Martins S.B.
        • Michel M.C.
        • Wang D.
        • Tu S.W.
        • Clark D.J.
        • Elliott J.
        • Vucic B.
        • Balt S.
        • Clark M.E.
        • Sintek C.D.
        • Rosenberg J.
        • Daniels D.
        • Goldstein M.K.
        Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain.
        Implement Sci. 2010; 5: 26
        • Trescot A.M.
        • Helm S.
        • Hansen H.
        • Benyamin R.
        • Glaser S.E.
        • Adlaka R.
        • Patel S.
        • Manchikanti L.
        Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
        Pain Physician. 2008; 11: S5-S62
        • Vieweg W.V.
        • Lipps W.F.
        • Fernandez A.
        Opioids and methadone equivalents for clinicians.
        Prim Care Companion J Clin Psychiatry. 2005; 7: 86-88
        • Von Korff M.
        • Saunders K.
        • Ray G.T.
        • Boudreau D.
        • Campbell C.
        • Merrill J.
        • Sullivan M.D.
        • Rutter C.M.
        • Silverberg M.J.
        • Banta-Green C.
        • Weisner C.
        De facto long-term opioid therapy for noncancer pain.
        Clin J Pain. 2008; 24: 521-527
        • Wagner A.K.
        • Soumerai S.B.
        • Zhang F.
        • Ross-Degnan D.
        Segmented regression analysis of interrupted time series studies in medication use research.
        J Clin Pharm Ther. 2002; 27: 299-309
        • Washington State Agency Medical Directors' Group
        Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain.
        Washington State Agency Medical Directors' Group, Olympia, WA2010 (Available at:)
      3. Washington State Department of Health: Washington State Department of Health Prescription Monitoring Program (PMP). Available at: http://www.doh.wa.gov/PublicHealthandHealthcareProviders/HealthcareProfessionsandFacilities/PrescriptionMonitoringProgramPMP.aspx. Accessed October 5, 2012

      4. Washington State Department of Health: Pain management—Adopted rules. Available at: http://www.doh.wa.gov/PublicHealthandHealthcareProviders/HealthcareProfessionsandFacilities/PainManagement/AdoptedRules.aspx. Accessed May 31, 2013